Literature DB >> 20661371

The wrong drug problem continues.

Sarika Katiyar1.   

Abstract

Entities:  

Year:  2010        PMID: 20661371      PMCID: PMC2900759          DOI: 10.4103/0019-5049.63645

Source DB:  PubMed          Journal:  Indian J Anaesth        ISSN: 0019-5049


× No keyword cloud information.
Sir, I read with interest the correspondence by Singh et al.[1] titled "The wrong drug problem continues". Medication error is a leading cause of morbidity and mortality in hospitalised patients. Due to high potency, variety and frequency of drugs administered to patients undergoing anaesthesia, the potential for errors exists, with disastrous consequences. The major cause of drug error is misidentification of drug ampoules or vials. Confusing, inaccurate or incomplete labels contributed to 21% of the actual or potential drug errors reported to the US Pharmacopoeia practitioners network over a one-year period (1999).[2] The American Society of Anaesthesiologists supports the manufacture and use of pharmaceuticals with labels meeting standards that are consistent with those established by the American Society for Testing and Materials (ASTM) International. The main change to the drug label is the introduction of a critical information panel or field. The label presents the generic name of the drug, the total amount per total volume and the drug concentration in black text on a white background. In addition, the drug's proprietary name, manufacturer, lot number, date of manufacture and expiry date should also be included on the label. The text on the label should be designed to enhance the recognition of the drug name and concentration as recommended in the ASTM International standards.[3] Maximum Contrast between the text and the background should be provided by high contrast colour combinations, as specified in section 6.3.1 of the ASTM International Standards, which also minimise the impact of colour blindness[3] [Table 1]
Table 1

Contrasting background for labels

TextBackground
BlackWhite
BlueYellow
WhiteBlue
BlueWhite
Contrasting background for labels Nine classes of drugs commonly used in the practice of anaesthesiology have a standard background colour established by the ASTM International standards for user-applied syringe labels. For these drugs the colour of the container top, label border and any other coloured area on the label, excluding the background, as required for maximum contrast; should be the colour responding to the drug's classification. [3] [Table 2] Essential information including the drugs generic name, concentration and volume of the vial or ampoule should be bar coded at a location on the vial or ampoule, which will not interfere with the labels legibility as specified in the ASTM International Standards.[4]
Table 2

Drug class and pantone colours

Drug ClassTextPantone colour
Induction agentsYellow
TranquilizersOrange
Muscle relaxantsFluorescent Red
Relaxant antagonistsLungFlorescent Red / White Diagonal stripes
NarcoticsBlue
Narcotic antagonistsBlue / White diagonal stripes
Major tranquilizersSalmon
Narcotic / Tranquilizer combinationBlue / Salmon
VasopressorsViolet
Hypotensive agentsViolet / White diagonal stripes
Local anaestheticsGrey
Anticholinergic agentsGreen
Drug class and pantone colours As described by Singh et al. the drug error was prevented by watching the volume of drug in the syringe. Moreover, the Bupivacaine ampoules (sterile ampoules) packing should not be opened. The packing should be opened only during spinal anaesthesia, as these ampoules are sterile and are to be loaded after all aseptic precautions. Current evidence indicates that improving clinical communication can also reduce medical error to some extent. Thus, drug errors are an inevitable consequence of the human condition, they occur even among the most conscientious medical professionals.
  2 in total

1.  Reducing medication errors.

Authors:  B Orser
Journal:  CMAJ       Date:  2000-04-18       Impact factor: 8.262

Review 2.  Aspects of a cognitive neuroscience of mental imagery.

Authors:  S M Kosslyn
Journal:  Science       Date:  1988-06-17       Impact factor: 47.728

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.